Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Mutation‐specific antibody detects mutant BRAFV600E protein expression in human colon carcinomas
Smyrk, Thomas C. , Tougeron, David , Thibodeau, Stephen N. , Singh, Shalini , Murányi, Andrea , Shanmugam, Kandavel , Grogan, Thomas M. , Shi, Qian , Sinicrope, Frank A. , Alberts, Steven R. , Shi, Qian , Tougeron, David

Cancer | May 8, 2013 | Volume: 119 | Issue: 15 | Pages: 2765-2770

10.1002/cncr.28133 | PMID 23657789 Get It

BACKGROUNDA point mutation (V600E) in the BRAF oncogene is a prognostic biomarker and may predict for nonresponse to anti‐EGFR antibody therapy in patients with colorectal carcinoma. BRAFV600E mutations are frequently detected in tumors with microsatellite instability and indicate a sporadic origin. We used a mutation‐specific antibody to examine mutant BRAFV600E protein expression and its concordance with BRAFV600E mutation data.METHODSPrimary stage III colon carcinomas were analyzed for BRAFV600E mutations in exon 15, and 50 BRAFV600E mutation carriers and 25 wild‐type tumors were selected for analysis of BRAF proteins by immunohistochemistry (IHC). IHC was performed in archival tissue specimens using a pan‐BRAF antibody and a mutation‐specific antibody against BRAFV600E proteins. Staining was scored by 2 pathologists who were blinded to clinical and mutation data.RESULTSUsing a pan‐BRAF antibody, total BRAF protein expression was observed in the tumor cell cytoplasm in 74 of 75 colon carcinomas. A mutation‐specific antibody identified diffuse cytoplasmic staining of mutant BRAFV600E proteins in 49 of 74 cancers. Analysis using a polymerase chain reaction‐based assay revealed that all 49 of these cancers carried BRAFV600E mutations. In contrast, BRAFV600E staining was absent in all 25 tumors that carried wild‐type copies of BRAF.CONCLUSIONSA BRAF mutation‐specific (V600E) antibody detected tumors with BRAFV600E mutations and exhibited complete concordance with a DNA‐based method. These results support the use of IHC as a simplified strategy to screen colorectal cancers for BRAFV600E mutations in clinical practice. Cancer 2013;119:2765–2770. © 2013 American Cancer Society.
Waldenström macroglobulinaemia: the key questions
D’Souza, Anita , Ansell, Stephen M. , Reeder, Craig B. , Gertz, Morie A. , D'Souza, Anita

British Journal of Haematology | May 8, 2013 | Volume: 162 | Issue: 3 | Pages: 295-303

10.1111/bjh.12367 | PMID 23651417 Get It

SummaryIn this review, the key issues that pertain to Waldenström disease are discussed in a concise question‐and‐answer format. Diagnosis, prognosis, and indications for state‐of‐the‐art therapy are updated. Current therapies presented at the 7th International Workshop for Waldenström Macroglobulinaemia are included.
Reticulated acanthoma with sebaceous differentiation: another sebaceous neoplasm associated with Muir-Torre syndrome?
Shon, Wonwoo , Wolz, Michael , Newman, Catherine C., Bridges, Alina G.

Australasian Journal of Dermatology | May 8, 2013 | Volume: 55 | Issue: 4 | Pages: e71-e73

10.1111/ajd.12058 | PMID 23651324 Get It

Moyamoya Disease in a Primarily White, Midwestern US Population
Bower, Regina S., Mallory, Grant W., Nwojo, Macaulay, Kudva, Yogish C. , Flemming, Kelly D. , Meyer, Fredric B. , Flemming, Kelly D

Stroke | May 8, 2013 | Volume: 44 | Issue: 7 | Pages: 1997-1999

10.1161/strokeaha.111.000307 | PMID 23652271 Get It

Background and Purpose— Moyamoya disease is an uncommon, cerebrovascular occlusive disease of unknown pathogenesis. Previously described Moyamoya cohorts include predominantly Asian populations or ethnically diverse North American cohorts. To gain further insight into the pathogenesis of moyamoya, we examined clinical characteristics of a primarily white, Midwestern US population Methods— Retrospective analysis of patients with angiographically confirmed moyamoya disease evaluated at our institution was performed. Prevalence of comorbidities, cerebrovascular risk factors, and autoimmune diseases were compared with the general population. Results— Ninety-four patients with moyamoya were evaluated; 72.3% were female. Ethnic composition was primarily white (85%). A significantly higher prevalence of autoimmune disease was seen, particularly type 1 diabetes mellitus (8.5% versus 0.4% in the general population) and thyroid disease (17.0% versus 8.0% in the institutional general patient population). Hyperlipidemia was also increased (27.7% versus 16.3% in the general population). Conclusions— This study of a unique, primarily white, Midwestern population of moyamoya patients demonstrates a significantly higher prevalence of autoimmune disease than in the general population. This supports a possible autoimmune component to the pathogenesis of moyamoya disease.
Extended Lymphadenectomy in Colon Cancer Is Debatable
Young‐Fadok, Tonia M., Murphy, Jamie

World Journal of Surgery | May 7, 2013 | Volume: 37 | Issue: 8 | Pages: 1799-1807

10.1007/s00268-013-2071-0 | PMID 23652354 Get It

AbstractExtended lymphadenectomy has gained considerable attention as an adjunct to conventional colon cancer surgery with the hope that it may potentially decrease local recurrence rates and improve cancer‐specific outcome measures. Despite the enthusiasm surrounding these techniques, it is difficult to establish any additional survival benefit associated with more comprehensive lymphadenectomy strategies when these are performed in addition to conventional colon cancer surgery. Furthermore, these techniques remain unproven by large randomized clinical trials. The appropriate indications for performing extended lymphadenectomy also remain unclear, and there is a lack of standardization with regard to surgical technique. Moreover, there are a number of confounding factors that frequently receive little attention when oncological outcome measures are reported following extended lymphadenectomy in the setting of colon cancer. The purpose of this review is to outline these confounding issues and discuss their impact on reports describing cancer‐specific outcome measures following the use of extended lymphadenectomy techniques. Furthermore, this review proposes that in light of the available published evidence, the role of radical lymphadenectomy is currently unproven, with large randomized clinical trials required in the future to determine whether there is a survival benefit for colon cancer patients.
Hb Grove City [β38(C4)Thr→Ser, A C C>A G C; HBB : c.116C>G]: A New Low Oxygen Affinity β Chain Variant
Taliercio, Rachel M., Ashton, Rendell W. , Horwitz, Leonard, Swanson, Kenneth C., Wendt, Patricia, Hoyer, James D., Oliveira, Jennifer L. , Herrick, Jennifer L.

Hemoglobin | May 7, 2013 | Volume: 37 | Issue: 4 | Pages: 396-403

10.3109/03630269.2013.789794 | PMID 23651408 Get It

Three-dimensional nonlinear inverse scattering: Quantitative transmission algorithms, refraction corrected reflection, scanner design, and clinical results
Wiskin, James , Borup, D.T., André, Michael P. , Greenleaf, James F. , Parisky, Yuri R., Klock, John , Johnson, Steven G.

The Journal of the Acoustical Society of America | May 7, 2013 | Volume: 133 | Issue: 5_Supplement | Pages: 3229-3229

10.1121/1.4805138 Get It

Research in quantitative whole breast ultrasound imaging has been developing rapidly. Recently, we published results from 2D transmission inverse scattering algorithms, based on optimization, incorporating diffraction, refraction, and limited multiple scattering effects, using data collected from an early prototype, which showed the feasibility of high resolution quantitative imaging of the breast tissue speed and attenuation, and concomitant refraction corrected reflection imaging. However, artifact problems in speed and attenuation result from the 2D algorithms and the data characteristics. The reflection algorithm uses the speed map to model refractive effects of rays, so these artifacts are unacceptable. The 3D inverse scattering algorithm presented here, using data from a new prototype, overcomes most of these artifacts. We then use a 3D refraction corrected 360° compounded reflection algorithm for high resolution speckle free reflection images. We discuss the transmission and reflection algorithms and the advanced scanner used to collect the data, as well as initial clinical results from the Mayo Clinic, Breast Cancer Imaging Center, Orange County, and the University California, San Diego. We show examples of cysts, fibroadenomas, calcifications, cancers, and DCIS, in dense, fatty, and average breast tissue, and compare these with hand-held ultrasound, MRI, and mammography, where available.
Sudden Cardiac Arrest in a Young Patient with Hypertrophic Cardiomyopathy and Zero Canonical Risk Factors: The Inherent Limitations of Risk Stratification in Hypertrophic Cardiomyopathy
Kohorst, John J. , Bos, J. Martijn , Hagler, Donald J. , Ackerman, Michael J. , Bos, Johan M

Congenital Heart Disease | May 7, 2013 | Volume: 9 | Issue: 2 | Pages: E51-E57

10.1111/chd.12073 | PMID 23648018 Get It

Reply to K. Orendi et al
Mrózek, Krzysztof , Maharry, Kati , Carroll, Andrew J. , Marcucci, Guido , Bloomfield, Clara D. , Nicolet, Deedra

Journal of Clinical Oncology | May 7, 2013 | Volume: 31 | Issue: 18 | Pages: 2361-2362

10.1200/jco.2013.49.2504 | PMID 23930275 Get It

Visual Loss in Early-Stage Chronic Lymphocytic Leukemia
Pulido, José S. , Patnaik, Mrinal M. , Gonsalves, Wilson I. , Zent, Clive S.

Journal of Clinical Oncology | May 7, 2013 | Volume: 31 | Issue: 17 | Pages: e280-e282

10.1200/jco.2012.46.7431 | PMID 23650405 Get It